Cited 0 times in 
Cited 0 times in 
The value of disease-free survival (DFS) and osimertinib in adjuvant non-small-cell lung cancer (NSCLC): an international Delphi consensus report
https://orcid.org/0000-0003-3490-2195Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.